Effect of resveratrol capsules on knee osteoarthritis symptoms and specific markers of joint breakdow

Not Applicable

Completed

• Conditions: Musculoskeletal Diseases; Gonarthrosis [arthrosis of knee]; Knee osteoarthritis

• Registration Number: ISRCTN75392625
• Lead Sponsor: niversity of Sulaimani

Brief Summary

2021 Results article in https://doi.org/10.1155/2021/3668568 (added 16/11/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-09-09
• Study Completion: 2020-10-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

Mild to moderate OA at both screening and baseline visits, as defined by the up-to-date revised American College of Rheumatology (ACR) criteria for diagnosis of knee OA

Exclusion Criteria

1. Patients with a history of rheumatoid arthritis, gout, severe ischaemic heart disease, heart failure, hepatic failure, renal failure
2. Consumption of non-steroidal anti-inflammatory drugs or corticosteroid drugs within 4 weeks of study, intra-articular injection within 3 months prior to the study recruitment
3. Pregnant or desire to become pregnant, or lactating women

Study & Design

• Study Type: Interventional
• Study Design: Not specified